February is American Heart Month, and the U.S. Food and Drug Administration has a tool to help you achieve a heart-healthy lifestyle. It’s called the Nutrition Facts Label, and it can be found on all packaged foods and beverages. Now in its twentieth year, the Nutrition Facts Label helps you track the various nutrients you [ Read More ]
Colored eggs are emblems of Easter. But eggs, when not handled with special care, can cause food poisoning, also called foodborne illness. Salmonella, an organism that causes nausea, vomiting, diarrhea, cramps, and fever, can be found on both the outside and inside of eggs that look perfectly normal. In otherwise healthy people, the symptoms generally [ Read More ]
Abbott announced that it has received U.S. Food and Drug Administration (FDA) clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, the first from Abbott to include a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients. This unique device is also equipped with built-in FreeStyle Auto-Assist [ Read More ]
February is American Heart Month, and the U.S. Food and Drug Administration has a simple tool to help you achieve a heart-healthy lifestyle! It’s called the Nutrition Facts Label, and you can find it on all packaged foods and beverages. The Nutrition Facts Label lets you know exactly what you’re eating and helps you track [ Read More ]
Confirmatory trials show significantly prolonged survival in patients; drug granted regular approval The U.S. Food and Drug Administration granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST). Today’s action also highlights an increase in overall patient survival when the drug is taken for 36 months [ Read More ]
Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread [ Read More ]